Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
Cancer is one of the leading causes of death in the industrialized world and represents a tremendous social and economic burden. As conventional therapies fail to provide a sustainable cure for most cancer patients, the emerging unique immune therapeutic approach of bacteria-mediated tumor therapy (...
Main Authors: | Sebastian Felgner, Dino Kocijancic, Michael Frahm, Ulrike Heise, Manfred Rohde, Kurt Zimmermann, Christine Falk, Marc Erhardt, Siegfried Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-02-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1382791 |
Similar Items
-
A Murine Model to Study the Antibacterial Effect of Copper on Infectivity of Salmonella Enterica Serovar Typhimurium
by: Robert H. Reed, et al.
Published: (2010-12-01) -
Changes in Antimicrobial Resistance in Salmonella enterica Serovar Typhimurium
by: Frederick J. Angulo, et al.
Published: (2000-08-01) -
Characterization of Novel Factors Involved in Swimming and Swarming Motility in Salmonella enterica Serovar Typhimurium.
by: Julia Andrea Deditius, et al.
Published: (2015-01-01) -
Mode of Entry and Survival of Salmonella Enterica Serovar Typhimurium in Trophoblast Cells
by: Nguyen, Tina
Published: (2017) -
aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant
by: Sebastian Felgner, et al.
Published: (2016-09-01)